Drugs / Nailprotex
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02464826 | Jul 2015 → Jun 2016 | paronychia, tinea unguium | Mahidol University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nailprotex | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02464826 ↗ |
| Action | Inhibit | “It is able to inhibit the fungal growth.” NCT02464826 ↗ |
| Route | Topical | “Nailprotex® is the novel topical treatment in onychomycosis and chronic paronychia.” NCT02464826 ↗ |